VitamFero

About:

VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology.

Website: http://www.vitamfero.com/en/

Top Investors: EASME - EU Executive Agency for SMEs, Karista, GO CAPITAL, Capagro, Val De France Angels

Description:

Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as: - Toxoplasma gondii (toxoplasmosis agent) - Neospora caninum (neosporosis agent) - Cryptosporidium parvum (cryptosporidiosis agent). With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.